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algorithm for management of knee osteoar-
thritis in clinical practiceIn December 2014, the European Society for Clinical and Economic
Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
(ESCEO) published an algorithm recommendation for the manage-
ment of knee osteoarthritis (OA) [1]. The algorithm set out, for the first
time, to provide practitioners with a step-wise, multi-modal approach
to therapy, allowing them to optimize OA management in daily
practice. Since 2014, this guidance document has received interna-
tional endorsement, with translation, adaptation to the local context,
and publication in China, Russia, and South-East Asia [2–4]. Subse-
quently, in 2016 the ESCEO published a supplement to this journal,
providing an updated assessment of the literature for selected
pharmacological interventions in OA and focusing on real-life data [5].
Following publication, the ESCEO sought to discover if the
degree of endorsement observed in the literature was reflected
by uptake of the algorithm in clinical practice. A survey was
conducted among physicians attending the 2015 WCO-IOF-ESCEO
Congress in Milan, Italy. Almost 200 completed questionnaires
were received mostly from orthopedists and rheumatologists
involved in the routine treatment of knee OA worldwide
(N ¼ 198 in Europe, Eastern Europe, Asia, Middle East, Canada,
and Latin America). Overall, physicians rated the ESCEO algorithm
with a mean score of 7.7 for utility, feasibility and suitability.
Detailed results of the survey were presented at the 2017 WCO-
IOF-ESCEO Congress in Florence, Italy to an audience of 800
physicians from Europe, Asia, North Africa, South and Central
America. This audience were asked to reflect on various aspects
of the algorithm, using tele-voting to record their responses. Tele-
voting confirmed the earlier assessment, with these physicians
rating the ESCEO algorithm in the higher range for utility, ease of
application (feasibility) and suitability to clinical practice.
The step-wise approach to patient management outlined in the
ESCEO algorithm was found to be in general agreement with the
approach adopted by physicians in clinical practice. Most physicians
(74%) preferred to use paracetamol for ≤14 days for the short-term
control of symptoms in OA, shifting to non-steroidal anti-inflamma-
tory drugs (NSAIDs; topical or short-term oral) if pain was not
controlled, on top of background therapy with symptomatic slow-
acting drugs for OA (SYSADOA). In line with a recent literature survey
demonstrating increasing evidence of safety issues with paracetamol,
including cardiovascular, gastrointestinal, and renal toxicity [6], over
half of physicians considered that paracetamol is not suitable for
medium to long-term control of OA pain. Thus, according to the
survey, while paracetamol remains a first-line option for rescue
analgesia in the short term, it seems that its recommendation for
use on a regular basis might be open for discussion. Rather, in Step
1 we recommend chronic use of a SYSADOA with demonstrated
efficacy, that is, prescription patented crystalline glucosamine sulfate,x.doi.org/10.1016/j.semarthrit.2017.07.002
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reativecommons.org/licenses/by-nc-nd/4.0/).plus short-term paracetamol only as rescue analgesia, as needed. As
such, the next review of the ESCEO algorithm, scheduled to start in
March 2018, will consider increasing knowledge of recent literature
and physician preferences to guide future recommendations for
optimizing the long-term management of knee OA using combination
therapies, in order to reduce the need for surgery [7].Olivier Bruyère, PhDa,n, Cyrus Cooper, MD, PhDb,c,
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